$CVM
Cel Sci Corp
NYSE · Healthcare · Biological Products, (No Diagnostic Substances) · Vienna, VA
CVM chart
What traders are saying about $CVM
Latest postsCel Sci Corp news
- (AMEX: CVM) Share Price, CVM Stock News, CVM Share Price & Updates
kalkine.ca ·
- CEL-SCI reports survival data from Multikine cancer study By Investing.com
Investing.com Canada ·
- CEL-SCI announces tumor response, analyses from Phase 3 study of Multikine
TipRanks ·
- CEL-SCI Presents New Phase 3 Multikine® Data at World Congress: Pre-Surgical Biomarkers Identify Head & Neck Cancer Patients Achieving 73% 5-Year Survival
Yahoo Finance ·
- CEL-SCI Invited to Deliver Keynote Address on Multikine at 6th World Congress on Otology, Rhinology and Laryngology
Yahoo Finance ·
- CEL-SCI Reports Fiscal Third Quarter 2026 Results
Yahoo Finance ·
- CEL-SCI Study Published in Peer-Reviewed Oral Oncology Supports Multikine's Biomarker Strategy and Potential Overall Survival Benefit Ahead of Head and Neck Cancer Confirmatory Registration Study
Yahoo Finance ·
- Leading Oncology Journal Accepts For Publication New CEL-SCI Multikine Phase 3 Data Demonstrating Overall Survival Benefit in Underserved Head and Neck Cancer Patients
Yahoo Finance ·
- CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine® to Market for Newly Diagnosed Head and Neck Cancer
Yahoo Finance ·
- CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care
Yahoo Finance ·
- CEL-SCI Announces Closing of Offering
Yahoo Finance ·
- CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy
Yahoo Finance ·
Cel Sci Corp key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$25.4M | -$26.9M | -$32.4M | -$36.7M |
| Diluted EPS | $-6.27 | $-15.31 | $-0.73 | $-0.87 |
| Total assets (year end) | $22.9M | $25.7M | $28.7M | $44.6M |
| Cash and equivalents (year end) | – | – | – | $18.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Cel Sci Corp
- Ticker
- CVM (NYSE)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Vienna, VA
- Incorporated in
- CO
- Fiscal year end
- September 30
- SEC CIK
- 725363
Frequently asked questions
What exchange is Cel Sci Corp listed on?
Cel Sci Corp trades on the NYSE under the ticker symbol CVM.
What industry is Cel Sci Corp in?
Cel Sci Corp is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Cel Sci Corp headquartered?
Cel Sci Corp's business address on file with the SEC is in Vienna, VA.
When does Cel Sci Corp's fiscal year end?
Cel Sci Corp's fiscal year ends on September 30.
How much revenue did Cel Sci Corp report?
Cel Sci Corp reported $264,033 in revenue for calendar year 2014, according to its SEC filings.